← Insider buys
STML

Stemline Therapeutics Inc

COO Kenneth Hoberman sold $130K of Stemline Therapeutics Inc

Sold$130,211
$4.97Price
26,191Shares
−3%Stake

What STML did after the filing

Prices for STML after this filing aren't in yet.

Traded Mon, Mar 9. Filed Fri, Mar 13, 5:31 PM ET, after the close. Not investment advice.